Podcasts about opioids

On this edition of Parallax Views, former CDC epidemiologist and physician Dr. Charles LeBaron joins us to discuss his explosive new book Greed to Do Good: The Untold Story of CDC's Disastrous War on Opioids. Drawing on his rare vantage point as a public health insider (with 28 years' experience at the CDC), clinician, and former pain patient, Dr. LeBaron argues that the CDC's 2016 opioid guidelines—meant to reduce overdose deaths—actually worsened the crisis. We explore how flawed data, political pressure, and a rigid, arguably even at times psuedo-scientific approach led to a policy that criminalized both doctors and patients, neglected the realities of chronic pain, and contributed to the ongoing epidemic of overdose deaths. Dr. LeBaron explains why the distinction between addiction and use of opioids as a legitimate chronic pain treatment matter, how voluntary guidelines became de facto law, and why Dr. LeBaron still sees value in the CDC as an institution and is not using the book to delegitimize it (ie: critique isn't alway for tearing down, but calling for reform).. This is a powerful and challenging conversation about public health, institutional accountability, and the human cost of well-intentioned but disastrous policy.

NPR and three public radio stations in Colorado filed a lawsuit against the Trump administration today. They argue the White House’s executive order calling on the Corporation for Public Broadcasting to cease federal funding to NPR and PBS is unconstitutional. The Trump administration has made deep cuts to universities, federal agencies, and cultural and historical institutions. Their goal is to undermine information gathering and education that doesn’t support the MAGA agenda. Opioid overdose deaths dropped nearly a quarter last year, thanks in part to medicines like Narcan. But the Trump administration wants to cut funding for Narcan, and experts worry that progress will be lost.  Four East LA artists in their early 20s formed an art collective called Asco in 1972, exploring police brutality, immigration, gender, and sexuality. They’re the subject of a new documentary.

This blog was created using Notebook LM.This podcast describes the FDA approval of Suzetrigine, a novel non-opioid medication intended for moderate to severe pain. It explains that Suzetrigine operates by inhibiting voltage-gated sodium channel 1.8, which are crucial for transmitting pain signals. 

In this episode of The Psychedelic Podcast, Paul F. Austin welcomes Bryan Hubbard, a prominent advocate for psychedelic-assisted therapies, particularly ibogaine in the treatment of opioid addiction and mental health disorders.  Find full show notes and links here: https://thethirdwave.co/podcast/episode-305/?ref=278 Update (May 2025): Days before this episode's release, the Texas House approved a Senate-backed bill to fund ibogaine research through a public-private partnership aimed at securing FDA approval. This vote marks a major milestone in the movement Bryan describes throughout this conversation. Bryan shares his journey from leading Kentucky's Opioid Abatement Advisory Commission to spearheading breakthrough ibogaine research initiatives in Texas. He articulates ibogaine's unique neurological properties, discussing how it can reset brain neurochemistry in 36 hours and potentially treat conditions from traumatic brain injury to Parkinson's disease. The conversation explores the spiritual dimensions of ibogaine experiences, the political landscape surrounding psychedelic medicine, and Bryan's ongoing efforts to medicalize ibogaine through FDA drug development trials, highlighting Texas as the next frontier for this life-saving research. W. Bryan Hubbard is the Executive Director of the American Ibogaine Initiative. He is the first and former Chairman and Executive Director of the Kentucky Opioid Abatement Advisory Commission. He concurrently served as Special Counsel to the Kentucky Attorney General's Office of Medicaid Fraud and Abuse Control and was its prior Executive Director. He served on the Kentucky Judicial Commission on Mental Health, the Kentucky Child Support Guidelines Commission, Mine Safety Review Board, and the Kentucky Office of Drug Control Policy's Recovery Ready Communities Advisory Council. He previously served as Commissioner of the Kentucky Department of Income Support wherein he led the Commonwealth's Social Security Disability and Child Support Enforcement systems. He practiced workers' compensation law representing Walmart, Tyson Foods, and Tennessee Valley Authority for sixteen years. During his practice years, he observed the predacious onset of Kentucky's Opioid Epidemic amid generational joblessness, poverty, disability, and substance use. He was raised in Virginia's coalfields and is the proud grandson of two grade-school educated coal miners on whose shoulders he stands. Highlights: Why ibogaine interrupts addiction instantly The Stanford study that changed everything Resetting brain neurochemistry in 36 hours From Parkinson's to PTSD: Ibogaine's broad applications The spiritual awakening dimension of treatment How pharmaceutical interests block breakthrough medicine Kentucky's lost opportunity: $42 million for research Texas as the new frontier for ibogaine medicalization Matrix pharmacology: Ibogaine's intelligent mechanism The political war over life-saving psychedelic medicine Episode Links Website American Ibogaine Initiative Instagram: @w_bryan_hubbard X (Formerly Twitter): @w_bryan_hubbard Linkedin Episode Sponsors: Golden Rule Mushrooms - Get a lifetime discount of 10% with code THIRDWAVE at checkout

Send us a textEpisode Summary: Dr. Andrew Chadeayne discusses the chemistry of psilocybin and other psychedelics, their potential therapeutic applications, and the challenges of commercializing them in a shifting biotech market. The conversation delves into the complexities of magic mushroom composition, debunking myths like "lemon tekking," and uncovers the booming, unregulated alternative products industry, including kratom and synthetic psilocybin analogs sold in vape shops.About the guest: Andrew Chadeayne, PhD is a chemist who also holds a law degree, specializing in patent law. He is the founder and CEO of CaaMTech, a startup specializing in the development of novel psychedelic compounds. Chadeayne collaborates with academic labs to advance psychedelic science while navigating the commercial landscape.Discussion Points:Psilocybin is a prodrug converted to psilocin, but magic mushrooms contain other psychoactive molecules like beta-carbolines, which may enhance effects by inhibiting degradation.Chadeayne's team develops psilocin prodrugs to shorten psychedelic trips, making clinical administration more manageable without altering effects.The "lemon tek" myth—that lemon juice converts psilocybin to psilocin—is false; it enhances absorption by extracting compounds, not altering chemistry.Magic mushroom bruising indicates psilocin degradation, as oxidized psilocin forms blue, inactive dimers.The multi-billion dollar alternative products industry sells kratom and synthetic psilocybin analogs, often mislabeled, in vape shops, raising safety and regulatory concerns.Kratom's minor alkaloid, 7-hydroxymitragynine, is ~40x more potent than morphine, with no reported overdoses but high habit-forming potential.Non-hallucinogenic serotonin 2A agonists, like those developed by CaaMTech's spinout, show promise for conditions like migraines without requiring a psychedelic trip.Related episode:M&M 71: Chemistry of Magic Mushrooms, DMT Analogues, Entourage Effects in Cannabis & Fungi, Novel Psychedelic Medicines, Psychedelic Startups | Andrew Chadeayne*Not medical advice.Support the showAll episodes, show notes, transcripts, and more at the M&M Substack Affiliates: KetoCitra—Ketone body BHB + potassium, calcium & magnesium, formulated with kidney health in mind. Use code MIND20 for 20% off any subscription (cancel anytime) Lumen device to optimize your metabolism for weight loss or athletic performance. Code MIND for 10% off Readwise: Organize and share what you read. 60 days FREE through link SiPhox Health—Affordable at-home blood testing. Key health markers, visualized & explained. Code TRIKOMES for a 20% discount. MASA Chips—delicious tortilla chips made from organic corn & grass-fed beef tallow. No seed oils or artificial ingredients. Code MIND for 20% off For all the ways you can support my efforts

Researchers Examine Nonopioid vs. Opioid Analgesics Effectiveness after Third Molar ExtractionsBy Today's RDH ResearchOriginal article published on Today's RDH: https://www.todaysrdh.com/researchers-examine-nonopioid-vs-opioid-analgesics-effectiveness-after-third-molar-extractions/Need CE? Start earning CE credits today at ⁠⁠⁠⁠⁠https://rdh.tv/ce⁠⁠⁠⁠⁠Get daily dental hygiene articles at ⁠⁠⁠⁠⁠https://www.todaysrdh.com⁠⁠⁠⁠⁠ Follow Today's RDH on Facebook: ⁠⁠⁠⁠⁠https://www.facebook.com/TodaysRDH/⁠⁠⁠⁠⁠Follow Kara RDH on Facebook: ⁠⁠⁠⁠⁠https://www.facebook.com/DentalHygieneKaraRDH/⁠⁠⁠⁠⁠Follow Kara RDH on Instagram: ⁠⁠⁠⁠⁠https://www.instagram.com/kara_rdh/

David Hart isn’t necessarily one of the  people you’d expect to be critical of the $7.4 billion multi-state opioid settlement reached with drug company Purdue. For 25 years, he was the assistant attorney general at the Oregon Department of Justice until his retirement last month, and he headed the department’s opioid litigation and recovery/pharmaceutical fraud unit. One way or another, he’s represented the state in opioid litigation and negotiations since 2004. But since he’s now retired, he feels an obligation to speak out about a settlement that he says is far too lenient and favorable to the Sackler family and their company, Purdue. Hart describes their behavior in igniting and fueling the opioid crisis “the worst of the worst.” He spoke with our news partner The Lund Report about his concerns and wrote an op-ed in the Oregonian/Oregonlive. He joins us to detail his concerns and how he’s making his case to the attorneys general in Oregon and the other states involved.

Kyle Santoro, a 19-year-old filmmaker, created the documentary "Fentanyl High" to explore teenage psychology behind substance abuse after witnessing overdoses at his high school. His film takes a peer-to-peer approach to addiction education, removing stigma and creating spaces for vulnerable conversations about why teens turn to substances.Kyle and Dr Grover discuss his experiences making the film and what he has learned through making it:• Kyle began the project after a classmate overdosed in a school bathroom and administrators never acknowledged the incident• Traditional school responses to substance use often involve punishment and shame rather than compassion and understanding• Several teens who participated in making the documentary achieved sobriety through the therapeutic process of sharing their stories• Film screenings serve as community events with resources, panel discussions, and free naloxone distribution• Schools often resist hosting screenings due to fear of being labeled as having a drug problem• The documentary has been screened across multiple states creating a "domino effect" of awareness in communities• Kyle raised $75,000 to produce the film through community sponsors and organizations• Prevention efforts need more youth representation to create effective messaging that resonates with teens• The film emphasizes the importance of parents maintaining open communication with their teenagersIf you want to learn more about Kyle's film, visit fentanylhigh.com.To contact Dr. Grover: ammadeeasy@fastmail.com

Drug overdose deaths in the U.S. plunged last year to their lowest level since 2019, according to the CDC. In 2024, nationwide overdose deaths fell by nearly 30,000 from the year before, a drop of about 27 percent. There were declines across all categories of drug use, including opioids, the source of most overdose deaths over the past decade. John Yang discussed more with Brian Mann of NPR. PBS News is supported by - https://www.pbs.org/newshour/about/funders

Drug overdose deaths in the U.S. plunged last year to their lowest level since 2019, according to the CDC. In 2024, nationwide overdose deaths fell by nearly 30,000 from the year before, a drop of about 27 percent. There were declines across all categories of drug use, including opioids, the source of most overdose deaths over the past decade. John Yang discussed more with Brian Mann of NPR. PBS News is supported by - https://www.pbs.org/newshour/about/funders

On this West Virginia Morning, the state Supreme Court declined to rule in an opioid settlement lawsuit and schools assess effects of cuts to local food purchasing program. The post Opioid Settlement Suit Drags On And Schools Lose Local Food Funding, This West Virginia Morning appeared first on West Virginia Public Broadcasting.

In this audio summary, Shannen Schultz asks, for teleost fish undergoing surgical coeliotomy, do intramuscular exogenous opioids reduce perioperative pain, compared with no analgesia? Read the full Knowledge Summary here. Audio Summaries are a free resource that enable vets and vet nurses to more quickly and more easily access and digest relevant and up-to-date evidence! A time-saving way to make better and faster evidence-based decisions.

3pm: Guest - Tom Feegle - Beond.US - Ibogaine Therapy Clinic in Cancun // Ibogaine Therapy is breaking new ground in treating opioid addiction, PTSD and Traumatic Brain Injuries… PERMANENTLY // Twiggy Curley has Joined the Family! // 56% of pet owners would cut their own lives short to extend their pet’s, survey finds // John’s Plan to build a mini-sailboat for his cellphone

Jeff Lott once thought the NET Recovery device sounded too good to be true. Today, he's the Communications Director for the company behind it. In this episode, Jeff shares how a chance family connection led him into the heart of a growing movement to transform withdrawal and recovery. Developed from an accidental discovery involving electro-acupuncture, NET Recovery uses a small device to ease withdrawal symptoms and eliminate cravings in just a few days—without the use of medication. It's already changing lives in jails and treatment centers, offering a third path that doesn't fit the usual “medicated or abstinent” binary. Jeff walks us through the origins of NET Recovery, the clinical trial process, and the roadblocks they face in gaining acceptance—despite promising results. If you care about innovation in addiction recovery, this is a conversation you won't want to miss.

In this explosive episode, I'm joined by JC Shepard, CEO of the most advanced fentanyl test strip company on the market. We confront a chilling reality: fentanyl is now the #1 cause of death for Americans under 49. We dig into two disturbing possibilities: a globalist agenda designed to profit from destabilization, or Chinese payback disguised as chemical warfare. Shepard's breakthrough test strips, 10 times more sensitive than others, could be a critical weapon in this fight. With the southern border wide open and synthetic opioids flooding the nation, the stakes are higher than ever — and the silence from leadership speaks volumes.Learn more at https://theFentanylTest.com – and use code “SARAH” to save 10% if you decide to buy these life saving strips for you, your family. or your community. Save lives and have Fentanyl Test strips on hand. Buy now at https://theFentanylTest.com – use code “SARAH” to save 10%As promised in the show, here are the 16 Democrats who voted against the HALT Fentanyl Act:Alsobrooks (D-MD)Blunt Rochester (D-DE)Booker (D-NJ)Duckworth (D-IL)Hirono (D-HI)Markey (D-MA)Merkley (D-OR)Murphy (D-CT)Padilla (D-CA)Sanders (I-VT)Schiff (D-CA)Van Hollen (D-MD)Warnock (D-GA)Warren (D-MA)Welch (D-VT)Wyden (D-OR)

We exist in a neurochemical marketplace where external validation operates as both currency and drug—a psychological opioid creating temporary inflation of self-worth while depleting intrinsic value reserves.

Dr. Alex Walley, professor of medicine at the Boston University Chobanian and Avedisian School of Medicine, addresses the opioid overdose crisis and community engagement, topics at the Rhode Island's Community Overdose Engagement (CODE) Summit; Sean Graham, Deputy Director of Emergency Preparedness for the State of Georgia Department of Public Health, discusses the importance of radiological preparedness; ASTHO resources for Mental Health Awareness Month; Dr. Victor Ramos Otero, Secretary of Health for the Puerto Rico Department of Health, honored at the 11th Preventive Health and Immunization Congress for his leadership and accomplishments. Rhode Island's Community Overdose Engagement (CODE) Initiative and Summit National Alliance for Radiation Readiness ASTHO: Public Health's Role in Mental Health Promotion and Suicide Prevention Victor Ramos Otero, MD, Puerto Rico Department of Health  

The opioid epidemic is not just exacerbating our issues with crime, homelessness and public health, it's also harming our next generation — a warning that local entrepreneur Cammy Livingston is trying to spread by cofounding Generation O: The National Organization for Opioid-Exposed Children, a national nonprofit led by foster/adoptive moms across the U.S. to advocate for kids impacted by the opioid crisis. She explains more about why you haven't heard about this problem and what her organization is doing now to change that.

Journalists from around the state discuss the news of the week with host Bill Bryant, including preparations for the Kentucky Derby in Louisville. Guests: Janet Patton, Lexington Herald-Leader; Russ Cassady, Appalachian Newspapers; and Mario Anderson, Spectrum News 1.

Like so many other Americans, Chris Cella fell out of the middle class and became an opioid addict. Here's how he came back. (00:00): Introduction (02:00) Cella's Opioid Addiction (09:00): Gateway Drugs Are a Real Concern (24:57) Burning Down the Entourage House (39:25) What It's Really Like in Rehab Paid partnerships with: Identity Guard: Get a 30-day free trial and over 60% off when you sign up a https://IdentityGuard.com/Tucker Tecovas: Get 10% off at tecovas.com/tucker Learn more about your ad choices. Visit megaphone.fm/adchoices

The Indiana Pacers are moving on to the second round of playoffs. A new tactical urbanism project is set up along a busy cross-section of Indianapolis neighborhoods. A massive art installation has a new permanent home at the International School of Indiana. A group of researchers are hoping to incorporate virtual reality gaming technology to teach people how to reverse an opioid overdose. Want to go deeper on the stories you hear on WFYI News Now? Visit wfyi.org/news and follow us on social media to get comprehensive analysis and local news daily. Subscribe to WFYI News Now wherever you get your podcasts. WFYI News Now is produced by Drew Daudelin, Zach Bundy and Abriana Herron, with support from News Director Sarah Neal-Estes.

Wednesday April 30, 2025 Walgreens to Pay $350 Million to Settle Opioid Case

Send us a textIn this episode of Going Under: Anesthesia Answered with Dr. Brian Schmutzler, Brian and Vahid take a deeper dive into the opioid epidemic. Where did it start? Who's to blame? And why is the United States the leader in this epidemic? Have a question for Dr. Brian Schmutzler? Submit them to any of the social media pages below or on his website at https://www.drbrianschmutzler.com/Facebook: https://www.facebook.com/drbrianschmutzlerInstagram: https://www.instagram.com/drbrianschmutzlerTikTok: https://www.tiktok.com/@drbrianschmutzler?lang=enProvider or Medical Student?? Subscribe to his Patreon Page to get exclusive content and access to Medical Blocks:https://www.patreon.com/user?u=89356957&utm_medium=clipboard_copy&utm_source=copyLink&utm_campaign=creatorshare_creator&utm_content=join_linkThanks to our show sponsor: Butterfly Networkhttps://store.butterflynetwork.com/us/en/?rsCode=BRIAN25Support the show

Listen in as our expert panel discusses medications for management of opioid use disorder. They'll review strategies to optimize buprenorphine use and clarify the role of methadone and naltrexone.Special guest:Tyler J. Varisco, PharmD, PhDUniversity of Houston College of Pharmacy Assistant Professor, Department of Pharmaceutical Health Outcomes and PolicyAssistant Director, The PREMIER CenterYou'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Stephen Carek, MD, CAQSM, DipABLM, Clinical Associate Professor of Family Medicine for the Prisma Health/USC School of Medicine Greenville Family Medicine Residency Program at the University of South Carolina School of Medicine, GreenvilleCraig D. Williams, PharmD, FNLA, BCPS, Clinical Professor of Pharmacy Practice at the Oregon Health and Science UniversityFor the purposes of disclosure, Dr. Varisco reports a financial relationship [cardiology, inflammatory bowel disease] with HEALIX Infusion Therapy (research consultant).The other speakers have nothing to disclose.  All relevant financial relationships have been mitigated.This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in March 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: FAQ: Management of Opioid Use DisorderChart: Treatment of Opioid WithdrawalFAQ: Treatment of Acute Pain in Opioid Use DisorderFAQ: Meds for Opioid OverdoseSend us a textIf you're not yet a subscriber, find out more about our product offerings at trchealthcare.com. Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

The opioid epidemic is a story about all of us. It's about the people we love, the people we've lost and the people we fear losing.  Medicine specialist Dr. Holly Geyer joins me to share from her book, “Ending the Crisis: Mayo Clinic's Guide to Opioid Addiction and Safe Opioid Use.” Resources: Mayo Opioid Resource Center and NFL Alumni page Faith Radio podcasts are made possible by your support. Give now: click here

We're getting an update on the status of Ohio's opioid settlement funds on this hour of All Sides.

In this powerful episode of The Why Intervention Podcast, host Christopher Doyle sits down with Aidan Morgan, who shares his harrowing journey from childhood experimentation to full-blown addiction and ultimately to recovery. Guest's Info Aidan Morgan is a remarkable example of transformation and resilience. After battling addiction from age 12, Aidan has now maintained sobriety for six years, completely rebuilding his life in the process. A native New Yorker with deep roots in his community, Aidan's journey from addiction to recovery showcases the power of human connection and the possibility of change even in the darkest circumstances. Now 28, Aidan has transformed from someone who couldn't be relied upon to the family member everyone calls first when they need help. His story provides both hope and practical insights for families struggling with a loved one's addiction. With honesty, humility, and occasional humor, Aidan shares his personal experiences not as an expert but as someone who's lived through the struggle and found his way to the other side. His story stands as powerful evidence that recovery is possible and that intervention can save lives. Highlights Why the "wait until they hit bottom" approach is DANGEROUS and potentially DEADLY in today's world where "you could hit a casket before you hit bottom" The SHOCKING truth about what happened when Aidan nearly died in a car accident while high - and why it STILL wasn't enough to make him stop The DEVASTATING "9-HOUR DECISION" phenomenon that explains why addicts can't stop using even when they desperately want to and have days of abstinence Why your addicted loved one already has ENOUGH PAIN to change - they just need the right connection and opportunity NOW How Aidan's father's surprising SILENCE became the catalyst that finally broke through when nothing else would The COUNTERINTUITIVE reason why taking away a teen's activities as punishment for substance use actually ACCELERATES their addiction The BIZARRE encounter with "Franklin" that kept Aidan from walking out of detox over a veggie burger Why an addict telling you "I promise I'll stop" and ACTUALLY MEANING IT still isn't enough to overcome addiction The EMOTIONAL MOMENT when a father's three simple words - "It's over" - finally gave his son permission to surrender The PROFOUND TRUTH that most recovered addicts didn't seek help on their own - and what this means for your intervention strategy How Aidan went from being "the last person anyone would call" to handle a problem to becoming the family's MOST RELIABLE member If you're struggling with a loved one's addiction, this episode provides both the inspiration and practical framework for taking action before it's too late. Links and Resources from this Episode https://whyintervention.com/ https://twitter.com/whyintervention https://www.facebook.com/whyintervention/ https://www.instagram.com/whyintervention/ TIME SENSITIVE, FREE RESOURCE: Get an early preview of Christopher's new book "Stop Addiction Early: A Recovery Roadmap For Proactive Parents" at no cost for a limited time: https://helpthisbook.com/recoveryroadmapforparents/recovery-roadmap      Call to Action Schedule a Call Free Resources Review, Subscribe and Share If you like what you hear please leave a review by clicking here Make sure you're subscribed to the podcast so you get the latest episodes. Subscribe with Apple Podcasts Follow on Spotify Subscribe with RSS

Cassandra Matthews, creator behind Cass and the City and Kellen Matthews, founder of Philadelphia's Recovery Run Club join our Host Heather Major for the season 4 opener of Someone You Know.  In this episode, we discuss:         The turning point that inspired Kellen's Recovery.         The pivotal role connection has played in that journey, especially with family         The doctor that introduced Kellen to running and how it's led him to multiple 100 plus mile runs, as well as participating in at least one marathon a month in 2024.      A peek into how Cass is feeling about her own first race at this year's Independence Blue Cross, Broad Street Run, and the impact of social media to connect with and grow a community like this.  Today, the Recovery Run Club meets monthly and is for anyone on the recovery journey, as well as a place where loved ones and allies can show up and participate, too.  Hosted by Heather Major, Executive Director, Independence Blue Cross Foundation. Recovery is possible, and help is available. Please visit our website to learn how we are collaborating to address this crisis: www.ibxfoundation.org.  TM 2025 Someone You Know®. All Rights Reserved.  Disclaimers The information contained in this podcast is solely for informational purposes and should not replace advice from a medical provider when making healthcare decisions. This podcast contains opinionated content and may not reflect the opinions of any organizations this podcast is affiliated with. Nothing discussed in this podcast shall constitute or should be construed as endorsement by the Independence Blue Cross Foundation or Independence Blue Cross, LLC of any product or service discussed herein. We will discuss opioid use and opioid treatment, which may be triggering for some listeners. Listener discretion is advised. If you or someone you know is suffering from opioid addiction, please visit ibxfoundation.org/SYK.  Connect with the Independence Blue Cross Foundation! Learn how we're improving the health of the community: https://www.ibxfoundation.org/   Our blog and newsroom: https://infocus.ibxfoundation.org/   LinkedIn: https://www.linkedin.com/company/independence-blue-cross-foundation/   Instagram: https://www.instagram.com/ibxfdn/ Someone You Know Podcast: https://someoneyouknow.libsyn.com/

Renee Shaw recaps the Rx and Illicit Drug Summit 2025 with one-on-one interviews, including U.S. Representative Hal Rogers (R-KY5); U.S. Representative James Comer (R-KY1); U.S. Representative Brett Guthrie (R-KY2); and Nora Volkow, director of the National Institute on Drug Abuse.

We're getting an update on the status of Ohio's opioid settlement funds on this hour of All Sides.

Dr. Kaitlan Baston, former Commissioner of Health for the New Jersey Department of Health and an ASTHO Member, outlines what New Jersey has been doing to address opioids; Kate Murray, Program Supervisor for Long COVID and Post-COVID Conditions at the Minnesota Department of Health, discusses her program and how the work is going; an ASTHO webinar on May 1 focuses on Academic Health Departmetn Partnerships; and ASTHO Member and the New York Commissioner of Health, Dr. James McDonald, will speak at Blooming Day 2025 on May 2. New Jersey Department of Health News Release: NJ Health Department Announces Waiver to Improve Access to Opioid Treatment Services New Jersey Department of Health News Release: ICYMI – Governor Murphy Announces Jeff Brown to Serve as Acting Commissioner of the New Jersey Department of Health Minnesota Department of Health Web Page: Long COVID Resources and Support ASTHO Webinar: Pathways to Academic Health Department Partnerships: Successes and Best Practices Blooming Day 2025 Web Page  

Emi Chutaro, Executive Director of the Pacific Island Health Officers Association, explains what she hopes others gain from Pacific Islander Heritage Month; Paul Bonta, Director of Government Relations for the Safe States Alliance, tells us about his organization's most recent advocacy day; and a new ASTHO blog article highlights recent Congressional hearings focused on key challenges facing older adults. PIHOA Web Page National Archives Web Page: Asian American, Native Hawaiian, and Pacific Islander Heritage Month Safe States Alliance Web Page ASTHO Blog Article: Hearings Spotlight Inflation, Opioids, and Other Challenges Facing Older Adults ASTHO Web Page: State and Territorial Administrative Readiness (STAR) Center  

Welcome to another edition of Scheer Intelligence, where host Robert Scheer dives into critical discussions with renowned guests. Today, we have Dr. Charles LeBaron, a distinguished physician and CDC veteran, who has authored a compelling and essential book, 'Greed to Do Good: The Untold Story of the CDC's Disastrous War on Opioids.' Dr. LeBaron offers a unique perspective on the opioid crisis, drawing from his extensive experience and personal encounters. Through his well-crafted narrative, he sheds light on the complexities of pain management, the challenges of public health policies, and the human stories behind addiction. Join us as we explore these pressing issues with honesty and depth."

In Indiana last year, 30 people were killed and more than one thousand five hundred were injured in work zones. A bill signed by Governor Mike Braun expands the kinds of opioid-reversing medications that can be stocked in schools. Legislation that could fine and jail people sleeping on public land was removed from another bill, shortly before the end of session. Health officials are worried about language included in Indiana's budget bill that requires some health funds only be used for Indiana residents who are U.S. citizens. Want to go deeper on the stories you hear on WFYI News Now? Visit wfyi.org/news and follow us on social media to get comprehensive analysis and local news daily. Subscribe to WFYI News Now wherever you get your podcasts. WFYI News Now is produced by Drew Daudelin, Zach Bundy and Abriana Herron, with support from News Director Sarah Neal-Estes.

En este podcast, nos enfocamos en la crisis de los opioides y el aumento mortal del fentanilo. La Dra. Erica Locke y el enfermero Michael Isaacs, RN, analizan las duras realidades y las soluciones urgentes necesarias para combatir esta epidemia. Además, nos platican sobre el papel vital que desempeña nuestro sistema de salud en la lucha contra este problema urgente.

Many rural Ohio communities are receiving small settlements from opioid manufacturers. They're getting creative to ensure the small boost makes a large impact.

The latest North State and California news on our airwaves for Tuesday, April 22, 2025.

INterview with nurse practitioner Theresa Baxter

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter Sean Mackey is a professor of pain medicine at Stanford University and the director of the Stanford Systems Neuroscience and Pain Lab, where his research explores the neural mechanisms of pain and the development of novel treatments for chronic pain. In this episode, Sean joins Peter for a wide-ranging discussion on the multifaceted nature of pain—as both a sensory and emotional experience—and its evolutionary purpose as a critical survival mechanism. He dives into how pain is transmitted through the nervous system, the different types of pain, and why different individuals perceive pain so differently. Sean shares insights into pain management strategies ranging from medications like NSAIDs and opioids to neuromodulation techniques such as transcutaneous electrical nerve stimulation (TENS). Additionally, this episode explores the interplay between sleep and chronic pain and the psychological and emotional dimensions of pain, and it includes a personal story from Peter about his own experience with pain and how Sean's expertise helped him more than two decades ago. We discuss: The definition of pain, and how our understanding of pain has evolved from a simplistic body-mind separation to a nuanced biopsychosocial model [2:30]; The biological mechanisms behind how we perceive pain [9:30]; The role of consciousness in the perception of pain, and how nociception functions during unconscious states [14:30]; The four types of pain [22:00]; Using fMRI to identify objective biomarkers of pain in the brain [31:30]; The evolutionary role of pain in human behavior and survival [36:00]; How the brain processes and modulates pain signals, Gate Control Theory, the variability in individuals' pain perception, and effectiveness of neuromodulation techniques like TENS [41:00]; The brain's influence on pain: the role of emotion, beliefs, sleep, and individual differences in perception and tolerance [53:45]; Peter's personal journey with chronic back pain, and how the emotional consequences of pain can be more distressing than the pain itself [1:04:30]; The pharmacology of common pain medications—NSAIDs, COX-2 inhibitors, and acetaminophen [1:09:30]; Muscle relaxants: benefits, drawbacks, and personalized strategies [1:20:30]; The definition of chronic pain [1:29:15]; The role of antidepressants in pain management [1:30:15]; Opioids: their controversial and nuanced role in pain management [1:33:45]; Alternative therapies: acupuncture and cannabis [1:54:15]; Fibromyalgia and chronic pain: clinical features, brain mechanisms, and emerging treatments like low-dose naltrexone [2:01:00]; Possible brain benefits of low-dose naltrexone (LDN) for people with mild cognitive impairment [2:15:00]; Peter's recovery from severe chronic pain—how he went from immobility and high-dose opioids to full functionality [2:20:15]; Breaking the pain cycle: how physical rehabilitation and psychological recovery work together in chronic pain treatment [2:30:45]; Sean's struggle with cluster headaches, and the value of knowledge, preparation, and empathy in both managing chronic pain and caring for patients [2:39:15]; and More. Connect With Peter on Twitter, Instagram, Facebook and YouTube

Christy Jones, President and CEO of the Monday Solutions Group, details how leaders can benefit from skill development in preparation for several upcoming ASTHO Ignite Leadership Series webinars; Dr. Allison Arwady, Director of the National Center for Injury Prevention and Control at the CDC, tells us how data has influenced real change in the fight against opioids; and on Thursday, April 24, ASTHO will host a webinar on the benefits of Successful Academic Health Department Partnerships. ASTHO Webinar: Performance Management Techniques for Successful Decision-Making CDC Web Page: CDC Reports Nearly 24% Decline in U.S. Drug Overdose Deaths ASTHO Webinar: Exploring Successful Academic Health Department Partnerships ASTHO Web Page: Subscribe  

Dr. Julie Siemers is a healthcare leader with 40+ years of experience who teaches people how to survive hospital stays and avoid becoming a statistic. New episodes of Welcome to Wellness every Friday!Not listening on Spotify? Show notes at: https://www.ashleydeeley.com/w2w/drjuliesiemersEpisode brought to you by: ApolloNeuroEpisode brought to you by:⁠⁠⁠⁠⁠⁠ VieLight⁠⁠⁠ - ⁠⁠⁠Code: DEELEY10Episode brought to you by:⁠⁠⁠⁠⁠⁠Dry Farm Wines⁠⁠⁠⁠⁠⁠ 8:57: Surviving Your Hospital Stay - book13:31:  Hospital Hierarchy: NurseCharge nurseHouse supervisorAdministrator14:59: CUSS words: Tell your nurse, "I feel..."ConcernedUncomfortableScaredSafety22:55: The 3 P'sBe presentBe politeBe persistent 24:39: Find the ranking of hospitals! https://www.hospitalsafetygrade.org/28:38: Patient left with a retractor insider her body30:48:  1 out of 4 Medicare patients that enter the hospital have some kind of harm happened to them34:35: Vital signsBlood pressure: normal is considered to be less than 120/80 mmHgHeart rate: normal resting heart rate is between 60 and 100 beats per minute (bpm)Respiratory rate: this is THE MOST SENSITIVE  and earliest indicator of patient deterioration; normal range is 12 to 20 breaths per minute 37:24: 80% of nurses don't count respiratory rate 38:51: Blood pressure cuff40:04: Opioids, Sleep Apnea, and Surgery44:11: The best thing to do if you need surgery - GET MOVINGIt boosts blood flow to your extremities, helping prevent deep vein thrombosis (DVT) or blood clots, which often start in the legs. It also supports lung expansion and overall circulation45:14: Invest in an  incentive spirometer (to ensure you have it after surgery)47:52: Symptoms of  low or high blood pressure, heart rate, respiratory issuesDizzyDehydratedTemperature irregularitiesHeart beat irregularities55:21: Protocol for a feeding tube58:08: Medication errors are a top problem in hospitals58:30: ALWAYS ask for test results/lab results/pathology reports1:02:59: Patient Safety Checklist1:04:33: Always double check that your name and patient details are correct on all forms, blood samples, etc.,1:08:28: Why Dr Siemers is against statins (as am I!)Where to find Dr. Julie Siemers⁠Website⁠InstagramFacebookYouTubeWhere to find Ashley Deeley:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Website⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube⁠⁠⁠⁠⁠⁠⁠⁠⁠hello@ashleydeeley.com

Opioid toxicity is a major and growing challenge across the UK and beyond, with nearly 10 deaths every day from opioid overdose and over a million adults using Class A drugs annually, the impact on emergency services is enormous. In this episode, we're diving deep into the recognition and management of acute opioid toxicity in the emergency setting, including the reversal using naloxone. We'll run through; The scale of the problem, including the rise of novel synthetic opioids like fentanyl and nitazenes. A breakdown of opioid pharmacology, including receptor types, potencies, and onset of action. How to identify classic and mixed presentations of opioid overdose. Best practice on naloxone dosing, routes of administration, and when to start infusions. The risk of acute withdrawal and how to manage it with care. How to approach mixed overdoses, cardiac arrests involving opioids, and nebulised naloxone. And finally, the importance of holistic care, safeguarding, and onward referral to support recovery. Whether you're in ED, prehospital care, or just want to sharpen your tox knowledge, this episode's packed with take-home learning. Oh, and yes... Gangs of London gets a shout-out too. Once again we'd love to hear any thoughts or feedback either on the website or via X @TheResusRoom! Simon, Rob & James

April 14, 2025 - State Opioid Settlement Fund Advisory Board Chair Debra Pantin discusses the flow of settlement funds, the board's future, and the impact of the Trump administration policies on overdose deaths.

Interview with Itai Danovitch, MD, author of Hospital Addiction Consultation Service and Opioid Use Disorder Treatment: The START Randomized Clinical Trial, and Michael A. Incze, MD, MSEd, author of Mortality Among Veterans With Opioid Use Disorder After Medical Hospitalization. Hosted by Eve Rittenberg, MD. Related Content: Hospital Addiction Consultation Service and Opioid Use Disorder Treatment Mortality Among Veterans With Opioid Use Disorder After Medical Hospitalization When Usual Care Is Subpar Care for Hospitalized Patients With Opioid Use Disorder

Click here to send us a topic idea or question for Weekend Wisdom.Are you considering adopting or fostering a child who was exposed prenatally to opioids or opioid-use treatment medication, such as Buprenorphine, methadone, and Suboxone? Are you a grandparent or aunt raising a child who was exposed? Join our discussion with Dr. Jennifer McAllister, the Medical Director of the NOWS Follow-Up Clinic at Cincinnati Children's Hospital Medical Center and the Medical Director of the University of Cincinnati Newborn Nursery.In this episode, we discuss:Terminology: What is the difference between opiates and opioids?What are the most common opioids being abused?What are the common treatment medications/drugs given to those with opioid use disorder? What are the brand names for these medications?How do these medications work?Are substance-use medications safe to use during pregnancy?What are the short- and long-term impacts on infants exposed to opioids?What are the short- and long-term impacts of infants exposed to opioid-use medications in pregnancy? Do the impacts differ?Does the dosage of opioid-use medications change the impact they have on the baby?What are the short- and long-term impacts of infants exposed to fentanyl in pregnancy?Is there a safer time for a fetus to be exposed to opioids or opioid-use medications in utero?Is it true that if the child is not born experiencing signs of withdrawal or with drugs in their system, the prognosis is better? Or conversely, if the child is born dependent and has to go through withdrawals, they will suffer more impact from in-utero drug exposure?How dangerous is drug dependency and withdrawal for the infant?How are Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS) treated in babies?If a mom is taking opioid-use medications during her pregnancy, is it recommended that she breastfeed the infant to help with withdrawal? How long does withdrawal in an infant born dependent last?How do you foster attachment while the baby is experiencing withdrawal?You often hear that “early intervention is key” and that a baby's brain can be rewired during the first couple of years with the right treatments or therapy. What exactly does that therapy entail? What strategies should you be using at home with your child with a diagnosis of prenatal drug exposure?When a child has drug exposure and trauma, is it possible to tell the difference in what is causing specific problems, and is the treatment different depending on the cause?Are children who are exposed prenatally to any drug, but specifically to opioids, at a greater risk for substance abuse disorder as teens and adults if they were adopted and not raised in an environment that exposed them to drug use?What are the most common blood-borne diseases that women who have IV drug use?What is the risk to a baby whose mother has HIV or Hepatitis C?Support the showPlease leave us a rating or review. This podcast is produced by www.CreatingaFamily.org. We are a national non-profit with the mission to strengthen and inspire adoptive, foster & kinship parents and the professionals who support them.Creating a Family brings you the following trauma-informed, expert-based content: Weekly podcasts Weekly articles/blog posts Resource pages on all aspects of family building

About this episode: People come to the emergency department seeking all kinds of urgent care. What if they could also get treatment for opioid addiction? In this episode: a look at how one rural hospital started prescribing buprenorphine to ER patients, and how scaling up treatment while reducing stigma at hospitals across the US is now helping thousands of patients every year. Guest: Arianna Campbell is an emergency department and addiction medicine PA at Marshall Medical Center in Placerville, California. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: USACS Physician Assistant, Ariana Campbell, PA-C, Aims to Eliminate the Stigma of Substance Use Through Education and Intervention—The Shift Blog The New Federal Regulations Aimed At Making Methadone More Accessible—And Less Stigmatizingcvb x—Public Health On Call (April 2024) A New Type of Overdose Response—Public Health On Call (March 2023) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

After reaching historic levels, fatal overdoses from opioids are dropping rapidly. Today we bring you a reporter's notebook from NPR's national addiction correspondent Brian Mann. He tells host Scott Detrow what it's been like to cover America's addiction crisis and explains the significance of the recent decline in opioid deaths. For sponsor-free episodes of Consider This, sign up for Consider This+ via Apple Podcasts or at plus.npr.org.Email us at considerthis@npr.org.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

America is facing a silent AND growing epidemic: the Adderall crisis. The use of this stimulant (and its generics) has exploded from 35.5 million prescriptions in 2019 to 45 million in 2022. But these numbers only scratch the surface. The DEA warns we're on the brink of our next drug crisis.  America is facing a silent AND growing epidemic: the Adderall crisis. The use of this stimulant (and its generics), known by street names like A-Train, Addy, Amps, Christmas Trees, Co-Pilots, Lid Poppers, Smarties, Study Buddies, and Study Skittles has exploded from 35.5 million prescriptions in 2019 to 45 million in 2022. But these numbers only scratch the surface. A dangerous black market has emerged, flooding streets with counterfeit pills indistinguishable from the real thing. Users, often unaware, risk their lives with every dose. Even legitimate prescriptions carry significant dangers. The DEA warns we're on the brink of our next drug crisis. With 5-6 million Americans using Adderall without proper diagnosis and one in four teens in some schools abusing prescription stimulants, we're watching a new generation spiral into un-prescribed/unneeded use and addiction. Thank you to our sponsors: FYSI: Visit https://FYSI.com/DRPHIL  or call 800-877-4000 Zecliner: Visit https://Zecliner.com  today PureHealth Research: Head over to https://PureHealthResearch.com  and save 35% with code PHIL Preserve Gold: Visit: https://drphilgold.com/   Get a FREE precious metals guide that contains essential information on how to help protect your accounts. Text “DRPHIL” to 50505 to claim this exclusive offer from Preserve Gold today.  

In this episode, I'm joined by Brigham Buhler, a passionate advocate for transforming the healthcare system. Brigham shares his personal journey and insights into the flaws in both the pharmaceutical industry and our healthcare system, offering solutions to help us all take control of our health.We discuss the brokenness of insurance, the opioid crisis, and the role of compounding pharmacies in providing personalized care. Brigham also talks about the power of functional medicine and why it's crucial for us to educate both the public and politicians about these pressing issues.Topics Discussed:Brigham's journey through the pharmaceutical industryThe opioid and fentanyl crisisThe flaws in the healthcare and insurance systemsFunctional vs. allopathic medicineThe benefits of compounding pharmaciesEducating the public and politicians on healthcare reformSponsored By:Be Well By Kelly Protein Powder & Essentials | Get $10 off your order with PODCAST10 at bewellbykelly.com.AG1 | Get a FREE 1-year supply of Vitamin D3+K2 AND 5 free AG1 Travel Packs with your first subscription at drinkAG1.com/bewell.We Natal | You can use my link, wenatal.com/kelly, with any subscription order, to get a free one month supply of WeNatal's Omega DHA+ Fish Oil valued at 35 dollars.Fatty 15 | You get an additional 15% off their 90-day subscription Starter Kit by going to fatty15.com/KELLY15 and using code KELLY15 at checkout..Timestamps: 00:00:00 - Introduction01:54:00 - Brigham's background05:32:00 - From pharmaceutical rep to healthcare advocate09:42:00 - The opioid epidemic14:06:00 - Solutions to the opioid crisis19:01:00 - The pharmaceutical industry breakdown27:02:00 - Insurance & chronic disease33:32:00 - Insurance companies and patient struggles37:06:00 - Rising insurance premiums41:40:00 - Functional vs. allopathic medicine43:31:00 - Integrative doctors46:12:00 - GLP-1s (Ozempic)47:33:00 - Health Senate roundtable & MAHA52:58:00 - Informed consent54:49:00 - Educating the public58:31:00 - Educating politicians01:00:15 - Taking control of your health01:04:26 - Traditional vs. compounding pharmaciesCheck Out Brigham:https://ways2well.comInstagramTwitter Check Out Kelly:InstagramYouTubeFacebookMentioned in this episode:Be Well By Kelly Protein Powder & Essentials | Get $10 off your order with PODCAST10 at bewellbykelly.com.